US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.291
- -0.054-4.01%
Trading Dec 19 10:19 ET
106.58MMarket Cap-0.51P/E (TTM)
1.400High1.290Low474.25KVolume1.400Open1.345Pre Close630.47KTurnover0.61%Turnover RatioLossP/E (Static)82.55MShares11.58052wk High0.61P/B99.83MFloat Cap1.29052wk Low--Dividend TTM77.32MShs Float99.950Historical High--Div YieldTTM8.18%Amplitude1.290Historical Low1.329Avg Price1Lot Size
About Editas Medicine Company
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolEDIT
Company NameEditas Medicine
Listing DateFeb 3, 2016
Issue Price16.00
Founded2013
CEODr. Gilmore O’Neill, M.B.
MarketNASDAQ
Employees265
Fiscal Year Ends12-31
Address11 Hurley Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-401-9000
Company Executives
- Name
- Position
- Salary
- Dr. Gilmore O’Neill, M.B.
- Director, Chief Executive Officer and President
- 2.39M
- Linda Burkly
- Executive Vice President and Chief Scientific Officer
- 1.54M
- Dr. Baisong Mei, M.D.
- Executive Vice President and Chief Medical Officer
- 1.14M
- Erick J. Lucera, C.F.A.
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.22M
- Emma Reeve
- Chairman of the Board
- 238.24K
- Dr. Meeta Chatterjee, PhD
- Independent Director
- 205.56K
- Bernadette M. Connaughton
- Independent Director
- 215.06K
- Dr. David T. Scadden, M.D.
- Independent Director
- 213.06K
- Dr. Jessica Hopfield, PhD
- Independent Director
- 231.07K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 264.88K
- Andrew J. Hirsch
- Independent Director
- 210.56K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
